Why the study?
Does alpha-human atrial natriuretic peptide infusion enhance sodium excretion in normal subjects?
Does alpha-human atrial natriuretic peptide infusion enhance sodium excretion in normal subjects?
Alpha-human atrial natriuretic peptide acts as a circulating factor that significantly enhances sodium excretion and diuresis in humans.
Answers are grounded in this paper and cite their sources.
Supports ANP as endogenous natriuretic factor in humans; leaves open therapeutic exploration in volume overload.
For many years experimental evidence has suggested the existence of a circulating factor able to enhance sodium excretion. Very recently peptides with natriuretic activity in experimental animals have been isolated from mammalian and human cardiac tissue. In order to determine whether this natriuretic activity has relevance to man we have studied the effects of an infusion of alpha-human atrial natriuretic peptide (alpha-h-ANP) in normal subjects. Sodium excretion trebled (P = less than 0.005) during the infusion of a calculated dose of 15 pmol of alpha-h-ANP min-1 kg-1 and there was an accompanying diuresis; radioimmunoassay of plasma alpha-h-ANP during the natriuresis indicated a mean peak incremental concentration of 203 +/- 78 (SEM) pmol/l. The infusion of a calculated dose of 1.5 pmol min-1 kg-1 did not affect sodium excretion. There were no haemodynamic changes and no side effects were noted.
No takes yet. Share an insight, caveat, or question.
Anderson et al. (1986) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: